|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 181.5 NOK | +0.83% |
|
+3.12% | -15.19% |
| Apr. 25 | Transcript : Medistim ASA, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 24 | Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024 | CI |
Medistim ASA reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was NOK 129.26 million compared to NOK 116.13 million a year ago. Net income was NOK 25.67 million compared to NOK 23.73 million a year ago.
Basic earnings per share from continuing operations was NOK 1.41 compared to NOK 1.3 a year ago. Diluted earnings per share from continuing operations was NOK 1.4 compared to NOK 1.3 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.19% | 300M | |
| +7.15% | 220B | |
| +6.60% | 183B | |
| +9.86% | 133B | |
| +24.32% | 107B | |
| -0.95% | 63.05B | |
| +11.04% | 51.74B | |
| +4.81% | 50.47B | |
| -1.43% | 40.91B | |
| +24.40% | 31.91B |
MEDISTIM ASA 
